(E)-N-[4-(3-ethynylanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(1,4-oxazepan-4-yl)but-2-enamide | 749879-57-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: (E)-N-[4-(3-ethynylanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(1,4-oxazepan-4-yl)but-2-enamide
• CAS: 749879-57-0
• 化学式: C₂₉H₃₁N₅O₄
• 分子量: 513.596
• InChiKey: XPCVYKLJAZBGJP-WAWJGKILSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  38
• 可旋转键数：
  9
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.34
• 拓扑面积：
  97.8
• 氢给体数：
  2
• 氢受体数：
  8

文献信息

• BICYCLISCHE HETEROCYCLEN, DIESE VERBINDUNGEN ENTHALTENDE ARZNEIMITTEL, IHRE VERWENDUNG UND VERFAHREN ZU IHRER HERSTELLUNG
  申请人：Boehringer Ingelheim International GmbH

  公开号：EP1597240B1

  公开（公告）日：2008-09-10
• Bicyclic heterocylces, pharmaceutical compositions containing these compounds, their use and processes for preparing them
  申请人：HIMMELSBACH Frank

  公开号：US20070185081A1

  公开（公告）日：2007-08-09

  The present invention relates to bicyclic heterocycles of general formula wherein R a , R b , R c , R d , R e and X are defined as in claim 1 , the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable pharmacological properties, particularly an inhibitory effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumoral diseases and benign prostatic hyperplasia (BPH), diseases of the lungs and respiratory tract, and the preparation thereof.
• US7223749B2
  申请人：——

  公开号：US7223749B2

  公开（公告）日：2007-05-29